<DOC>
	<DOCNO>NCT00988949</DOCNO>
	<brief_summary>This study Proof Mechanism ( POM ) study establish evidence central pharmacodynamic activity PF 04455242 , parallel group , randomize , double blind , sponsor open study conduct healthy male subject . Once subject achieve steady state PF 04455242 , undergo PF 00345768 ( spiradoline ) challenge . Data analyze determine whether PF-04455242 block spiradoline induce prolactin release .</brief_summary>
	<brief_title>Proof Of Mechanism Study To Determine Efficacy Of PF-04455242 In Blocking Spiradoline ( PF-00345768 ) Stimulated Prolactin Release</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Spiradoline</mesh_term>
	<criteria>Healthy male subject age 21 55 year , inclusive ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12 lead ECG clinical laboratory test . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) .</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Proof mechanism study</keyword>
</DOC>